针对系统性红斑狼患者EULAR建议的临床实施的实用见解
Ioannis Parodis1,2, Antonis Fanouriakis3, Alessandra Bortoluzzi4
1Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, and Center for Molecular Medicine (CMM), Stockholm, Sweden ioannis.parodis@ki.se.
RMD open
|December 31, 2025
概括
专家的见解为实施欧洲风湿病学协会联盟 (EULAR) 系统性红斑狼 (SLE) 管理指南提供了实际策略,旨在改善患者的治疗结果并预防器官损伤.
科学领域:
- 类风湿病学 类风湿病学
- 临床免疫学临床免疫学
- 内部医学 内部医学
背景情况:
- 欧洲风湿病学协会联盟 (EULAR) 的指导方针为管理全身性红斑狼 (SLE) 和狼性炎提供了关键的指导.
- 现实世界的实施面临实际挑战,包括实践者的时间限制.
研究的目的:
- 为在常规临床实践中有效实施EULAR SLE管理建议提供专家驱动的实际建议.
- 解决阻碍EULAR指导方针在日常患者护理中的障碍.
主要方法:
- 八名国际SLE专家参加了一项在线调查,其中包括17个开放式问题.
- 调查的回复集中在早期诊断,治疗目标,以及使用葡萄皮质激素 (GCs),免疫抑制剂和生物制剂.
- 通过汇编和分析调查结果,就关键建议点达成共识.
主要成果:
- 在四个关键主题中制定了13个核心专家建议点:设定标准化目标,实现目标,监测进展和优化治疗.
- 建议包括早期使用生物药物/免疫抑制剂的策略,确定预后风险因素,以及GC逐渐减少.
- 专注于预防爆发和GC相关的毒性,以改善疾病的过程和预防器官损伤.
结论:
- 专家的见解可以提高EULAR SLE管理建议的实际应用.
- 促进指南的实施有助于患者实现治疗目标,并降低器官损伤进展的风险.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
179
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
179
Rheumatic Heart Disease III: Medical Management
263
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
263
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
439
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
439
Rheumatic Heart Disease IV: Nursing Management
246
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
246
Nephrotic Syndrome III : Nursing Management
267
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
267
Atherosclerosis III: Management
291
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
291


